Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04018586 · ClinicalTrials.gov registry record · NA
AVACEN Hand Heating on Fasting Blood Glucose
A NA study of Hypertension and Hyperglycemia, sponsored by Jeff Moore.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT04018586: Completed NA study of Hypertension and Hyperglycemia, sponsored by Jeff Moore.
NCT04018586 is a NA study of Hypertension and Hyperglycemia that has completed, run by Jeff Moore. The registered enrollment target is 17 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04018586, a NA study of Hypertension and Hyperglycemia, has completed, sponsored by Jeff Moore.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
A double-blind crossover randomized controlled trial to investigate the effects of the AVACEN device on fasting blood glucose. The AVACEN device creates negative pressure around the hand while heating the palm. Two sham devices, one providing heat but no vacuum and one providing neither heat nor vacuum were also used. Each subject was tested while using each of these three devices on separate visits. Subjects arrived in the morning following an overnight fast. Fasting blood glucose, blood pressure, tympanic temperature, and subjective thermal ratings were measured before and throughout the 30 minutes that the device was used.
Primary Outcome
Change in fasting blood glucose after 30 minutes of use of AVACEN device
Conditions Studied
Interventions
- DEVICE AVACEN 100
- DEVICE AVACEN 100 Heat Only
- DEVICE AVACEN Sham
Study Locations (1)
California
- San Diego State University - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2019-02-28 |
| Est. Completion | 2019-09-15 |
| Phase | NA |
What the finished NCT04018586 record still lists
NCT04018586 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 3 interventions - of which AVACEN 100 is the first listed.
NCT04018586 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04018586 about?
NCT04018586 is a clinical study titled "AVACEN Hand Heating on Fasting Blood Glucose". A double-blind crossover randomized controlled trial to investigate the effects of the AVACEN device on fasting blood glucose. The AVACEN device creates negative pressure around the hand while heating the palm. Two sham devices, one providing heat but no vacuum and one providing neither heat nor vac...
What is the current status of trial NCT04018586?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2019-02-28. Estimated completion is 2019-09-15.
What conditions does trial NCT04018586 study?
This clinical trial studies the following conditions: Hypertension, Hyperglycemia.
What interventions are being tested in trial NCT04018586?
The interventions under investigation include: AVACEN 100 (DEVICE), AVACEN 100 Heat Only (DEVICE), AVACEN Sham (DEVICE).
Who is sponsoring clinical trial NCT04018586?
This trial is sponsored by Jeff Moore, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04018586 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04018586's enrollment target sits among peer trials
17 449th of 470 higher than 21 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI